Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9551-9600 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05708092
NRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE)
NAActive, not recruiting
1,032 participants
Started: Mar 22, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05037175
Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD
NAActive, not recruiting
360 participants
Started: Mar 22, 2022 · Completed: Jun 29, 2026
1 condition5 sponsors3 locations
NCT04980222
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
PHASE2Active, not recruiting
46 participants
Started: Mar 22, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor23 locations
NCT04571840
Prostate Imaging Using MRI +/- Contrast Enhancement
NAActive, not recruiting
500 participants
Started: Mar 22, 2022 · Completed: Mar 1, 2025
1 condition1 sponsor31 locations
NCT04655365
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
PHASE2Active, not recruiting
50 participants
Started: Mar 22, 2022 · Completed: Sep 1, 2026
1 condition2 sponsors4 locations
NCT05264545
Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients
NAActive, not recruiting
100 participants
Started: Mar 22, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors8 locations
NCT05202782
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
PHASE2Active, not recruiting
24 participants
Started: Mar 21, 2022 · Completed: Oct 9, 2029
19 conditions2 sponsors2 locations
NCT05015426
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1Active, not recruiting
20 participants
Started: Mar 21, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04754165
Postoperative VR for Recovery After Bariatric Surgery
NAActive, not recruiting
106 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT06007560
Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss
NAActive, not recruiting
30 participants
Started: Mar 21, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT05133427
HIFU for Treatment of Non-nodular and Recurrent BCC
NAActive, not recruiting
40 participants
Started: Mar 21, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors2 locations
NCT05077800
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer
PHASE2Active, not recruiting
70 participants
Started: Mar 21, 2022 · Completed: Jul 31, 2026
2 conditions3 sponsors3 locations
NCT05235061
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)
NAActive, not recruiting
160 participants
Started: Mar 21, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05020496
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
EARLY_PHASE1Active, not recruiting
70 participants
Started: Mar 21, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT04869917
Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care
NAActive, not recruiting
960 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06977217
Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern
N/AActive, not recruiting
270 participants
Started: Mar 21, 2022 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05235425
The Lifestyle Education About Prediabetes (Leap) Study
NAActive, not recruiting
300 participants
Started: Mar 20, 2022 · Completed: Nov 15, 2025
1 condition2 sponsors1 location
NCT04987489
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
PHASE2Active, not recruiting
60 participants
Started: Mar 20, 2022 · Completed: Sep 3, 2025
2 conditions1 sponsor16 locations
NCT05158517
VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER)
N/AActive, not recruiting
349 participants
Started: Mar 20, 2022 · Completed: Mar 20, 2025
1 condition2 sponsors1 location
NCT04993313
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study
NAActive, not recruiting
62 participants
Started: Mar 18, 2022 · Completed: Feb 28, 2026
17 conditions2 sponsors1 location
NCT05336526
Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation
NAActive, not recruiting
88 participants
Started: Mar 18, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor6 locations
NCT05592665
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
NAActive, not recruiting
42 participants
Started: Mar 18, 2022 · Completed: Jan 16, 2031
1 condition2 sponsors1 location
NCT05876533
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
N/AActive, not recruiting
216 participants
Started: Mar 18, 2022 · Completed: Mar 15, 2025
1 condition1 sponsor8 locations
NCT04577755
Pomalidomide Treatment in Patients With Kaposi Sarcoma
PHASE2Active, not recruiting
45 participants
Started: Mar 18, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor15 locations
NCT05375461
TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail
PHASE3Active, not recruiting
287 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05009069
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
PHASE2Active, not recruiting
58 participants
Started: Mar 18, 2022 · Completed: Nov 6, 2026
2 conditions1 sponsor5 locations
NCT05032976
Korea Comirnaty Post-marketing Surveillance
N/AActive, not recruiting
12,000 participants
Started: Mar 18, 2022 · Completed: Mar 4, 2027
5 conditions1 sponsor1 location
NCT04950868
The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
PHASE1Active, not recruiting
22 participants
Started: Mar 18, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT07055763
Effect Of Nigella Sativa Oil for the Treatment of Hypertension
NAActive, not recruiting
60 participants
Started: Mar 17, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05131607
21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial
NAActive, not recruiting
45 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT05279560
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
NAActive, not recruiting
114 participants
Started: Mar 17, 2022 · Completed: Jun 30, 2030
4 conditions1 sponsor1 location
NCT05120570
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2028
4 conditions1 sponsor1 location
NCT05313321
Survival of the Insignia Stem in Total Hip Arthroplasty
N/AActive, not recruiting
100 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04875754
A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05333068
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NAActive, not recruiting
1,222 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors49 locations
NCT05017740
PICSI RCT in Couples With a Previous Poor Fertilisation Cycle in IVF
NAActive, not recruiting
47 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05240131
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
PHASE1/PHASE2Active, not recruiting
88 participants
Started: Mar 15, 2022 · Completed: Nov 1, 2025
1 condition3 sponsors5 locations
NCT05248646
Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
PHASE3Active, not recruiting
530 participants
Started: Mar 15, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor297 locations
NCT05239728
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
PHASE3Active, not recruiting
1,800 participants
Started: Mar 15, 2022 · Completed: Sep 28, 2029
1 condition1 sponsor285 locations
NCT05307250
M-Suubi: A Multi-Level Integrated Intervention to Reduce the Impact of HIV Stigma
NAActive, not recruiting
1,851 participants
Started: Mar 15, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05031026
Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation
PHASE4Active, not recruiting
60 participants
Started: Mar 15, 2022 · Completed: Feb 15, 2026
1 condition1 sponsor1 location
NCT05527444
The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients
PHASE4Active, not recruiting
100 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05345600
MILTA vs Placebo Use Comparison for the Management of Pain Related to Perineal Scars Following Delivery
NAActive, not recruiting
110 participants
Started: Mar 15, 2022 · Completed: Jul 23, 2025
5 conditions1 sponsor1 location
NCT05285748
Comparing Self-paced Versus Moderate Intensity Physical Activity Recommendation for Midlife Adults
PHASE2Active, not recruiting
258 participants
Started: Mar 15, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05047055
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients
N/AActive, not recruiting
550 participants
Started: Mar 15, 2022 · Completed: Mar 31, 2025
1 condition6 sponsors1 location
NCT06209320
A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
PHASE3Active, not recruiting
777 participants
Started: Mar 15, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05096663
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2/PHASE3Active, not recruiting
82 participants
Started: Mar 15, 2022 · Completed: Dec 1, 2027
9 conditions2 sponsors350 locations
NCT06375668
The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women
NAActive, not recruiting
170 participants
Started: Mar 15, 2022 · Completed: Jun 15, 2024
2 conditions1 sponsor3 locations
NCT05971303
Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies
N/AActive, not recruiting
45 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04873245
Lifestyle Counseling and Medication for Adolescent Weight Management
PHASE2Active, not recruiting
120 participants
Started: Mar 15, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location